Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
18.18
-0.16 (-0.87%)
At close: Oct 17, 2025, 4:00 PM EDT
17.86
-0.32 (-1.76%)
After-hours: Oct 17, 2025, 5:47 PM EDT

Eton Pharmaceuticals Revenue

Eton Pharmaceuticals had revenue of $18.93M in the quarter ending June 30, 2025, with 108.60% growth. This brings the company's revenue in the last twelve months to $58.18M, up 85.40% year-over-year. In the year 2024, Eton Pharmaceuticals had annual revenue of $39.01M with 23.29% growth.

Revenue (ttm)
$58.18M
Revenue Growth
+85.40%
P/S Ratio
8.27
Revenue / Employee
$1,876,806
Employees
31
Market Cap
487.54M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202439.01M7.37M23.29%
Dec 31, 202331.64M10.39M48.90%
Dec 31, 202221.25M-581.00K-2.66%
Dec 31, 202121.83M21.79M55,879.49%
Dec 31, 202039.00K-920.00K-95.93%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings